1. Home
  2. EXTR vs STOK Comparison

EXTR vs STOK Comparison

Compare EXTR & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Extreme Networks Inc.

EXTR

Extreme Networks Inc.

HOLD

Current Price

$14.29

Market Cap

2.0B

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.00

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXTR
STOK
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
EXTR
STOK
Price
$14.29
$31.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$21.20
$34.50
AVG Volume (30 Days)
1.5M
727.4K
Earning Date
01-28-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
0.68
Revenue
$1,219,678,000.00
$205,632,000.00
Revenue This Year
$12.45
$430.24
Revenue Next Year
$7.33
N/A
P/E Ratio
$244.69
$42.94
Revenue Growth
20.02
1128.17
52 Week Low
$10.10
$5.35
52 Week High
$22.89
$38.69

Technical Indicators

Market Signals
Indicator
EXTR
STOK
Relative Strength Index (RSI) 31.12 51.70
Support Level $14.76 $28.75
Resistance Level $15.60 $30.25
Average True Range (ATR) 0.59 1.85
MACD -0.07 -0.08
Stochastic Oscillator 15.08 63.67

Price Performance

Historical Comparison
EXTR
STOK

About EXTR Extreme Networks Inc.

Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: